Background and Aims: Urinary neutrophil gelatinase associated lipocalin (uNGAL) and urinary kidney injury molecule-1 (uKIM-1) are markers of acute kidney injury. The albuminuria is a well-known abnormality after physical exercise. The aim of this study was to investigate changes in uNGAL and uKIM-1 after intensive exercise causing albuminuria. Methods: The study population consisted of 19 participants (10 males and 9 females). The mean age of participants was 35.74 years. All were fit amateur runners; the mean body mass index was 21.99 in females and 24.71 in males. The subjects underwent a graded treadmill exercise test (GXT) according to the Bruce protocol. Maximal oxygen consumption (VO2max) was measured. Immediately before and after the test urine was collected. Urinary creatinine, albumin, NGAL, and KIM-1 were measured. Albumin to creatinine (ACR), KIM-1 to creatinine (KCR), and NGAL to creatinine (NCR) ratios were calculated. Results: The mean VO2max was 53.68 in females and 59.54 mL/min/kg in males. Albuminuria and ACR were significantly higher after exercise. An increase in the ACR from 8.82 to 114.35 mg/g (p < 0.01) was observed. uKIM-1 increased significantly after exercise from 849.02 to 1,243.26 pg/mL (p < 0.05). KCR increased from 1,239.1 to 1,725.9 ng/g but without statistical significance (p = 0.07). There were no statistical changes in pre- and post-run uNGAL levels. There was no correlation between post-GXT albuminuria and uKIM-1. Conclusions: uKIM-1 is a very sensitive marker of kidney dysfunction. In our study, uKIM-1 increased significantly after a very short period of exercise. It is not clear if the increase in KIM-1 is caused by post-exercise albuminuria.

Keywords:
Albumin excretion, Acute kidney injury biomarkers, Exercise training
1.
Noakes T, Spedding M: Olympics: run for your life. Nature 2012;487:295-296.
2.
Merrill AJ, Cargill WH, Borders MA, Cavin E: The effect of exercise on the renal plasma flow and filtration rate of normal and cardiac subjects. J Clin Invest 1948;27:272-277.
3.
Middlekauff HR, Nitzsche EU, Nguyen AH, Hoh CK, Gibbs GG: Modulation of renal cortical blood flow during static exercise in humans. Circ Res 1997;80:62-68.
4.
McCullough PA, Chinnaiyan KM, Gallagher MJ, Colar JM, Geddes T, Gold JM, Trivax JE: Changes in renal markers and acute kidney injury after marathon running. Nephrology (Carlton) 2011;16:194-199.
5.
Neviackas JA, Bauer JH: Renal function abnormalities induced by marathon running. South Med J 1981;74:1457-1460.
6.
Junglee NA, Lemmey AB, Burton M, Searell C, Jones D, Lawley JS, Jibani MM, Macdonald JH: Does proteinuria-inducing physical activity increase biomarkers of acute kidney injury? Kidney Blood Press Res 2012;36:278-289.
7.
Poortmans JR, Rampaer L, Wolfs JC: Renal protein excretion after exercise in man. Eur J Appl Physiol Occup Physiol 1989;58:476-480.
8.
Poortmans JR, Blommaert E, Baptista M, De Broe ME, Nouwen EJ: Evidence of differential renal dysfunctions during exercise in men. Eur J Appl Physiol Occup Physiol 1997;76:88-91.
9.
Abdallah E, Waked E, Al-Helal B, Asad R, Nabil M, Harba T: Novel troponin-like biomarkers of acute kidney injury. Saudi J Kidney Dis Transpl 2013;24:1111-1124.
10.
Bruce RA, Cooper MN, Gey GO, Fisher LD, Peterson DR: Variations in responses to maximal exercise in health and in cardiovascular disease. Angiology 1973;24:691-702.
11.
Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-2100.
12.
Schrezenmeier EV, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM: Biomarkers in acute kidney injury - pathophysiological basis and clinical performance. Acta Physiol (Oxf) 2017;219:554-572.
13.
Fiseha T, Tamir Z: Urinary markers of tubular injury in early diabetic nephropathy. Int J Nephrol 2016;2016:4647685.
14.
Wasung ME, Chawla LS, Madero M: Biomarkers of renal function, which and when? Clin Chim Acta 2015;438:350-357.
15.
Hasegawa M, Ishii J, Kitagawa F, Takahashi K, Hayashi H, Koide S, Tomita M, Takahashi H, Ozaki Y, Yuzawa Y: Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease. Heart Vessels 2015;30:81-88.
16.
Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W: Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 2013;28:254-273.
17.
Kashani K, Cheungpasitporn W, Ronco C: Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption. Clin Chem Lab Med 2017;55:1074-1089.
18.
Singer E, Markó L, Paragas N, Barasch J, Dragun D, Müller DN, Budde K, Schmidt-Ott KM: Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf) 2013;207:663-672.
19.
Pozzoli S, Simonini M, Manunta P: Predicting acute kidney injury: current status and future challenges. J Nephrol 2017, Epub ahead of print.
20.
Kashani K, Cheungpasitporn W, Ronco C: Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption. Clin Chem Lab Med 2017;55:1074-1089.
21.
Park JT: Postoperative acute kidney injury. Korean J Anesthesiol 2017;70:258-266.
22.
Andreucci M, Faga T, Riccio E, Sabbatini M, Pisani A, Michael A: The potential use of biomarkers in predicting contrast-induced acute kidney injury. Int J Nephrol Renovasc Dis 2016;9:205-221.
23.
Junglee NA, Di Felice U, Dolci A, Fortes MB, Jibani MM, Lemmey AB, Walsh NP, Macdonald JH: Exercising in a hot environment with muscle damage: effects on acute kidney injury biomarkers and kidney function. Am J Physiol Renal Physiol 2013;305:F813-F820.
24.
Lippi G, Sanchis-Gomar F, Salvagno GL, Aloe R, Schena F, Guidi GC: Variation of serum and urinary neutrophil gelatinase associated lipocalin (NGAL) after strenuous physical exercise. Clin Chem Lab Med 2012;50:1585-1589.
25.
de Carvalho JA, Tatsch E, Hausen BS, Bollick YS, Moretto MB, Duarte T, Duarte MM, Londero SW, Premaor MO, Comim FV, Delanghe JR, Moresco RN: Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes. Clin Biochem 2016;49:232-236.
26.
Aslan O, Demir M, Koseoglu M: Kidney injury molecule levels in type 2 diabetes mellitus. J Clin Lab Anal 2016;30:1031-1036.
27.
Comper WD, Haraldsson B, Deen WM: Resolved: normal glomeruli filter nephrotic levels of albumin. J Am Soc Nephrol 2008;19:427-432.
28.
Russo LM, Sandoval RM, McKee M, Osicka TM, Collins AB, Brown D, Molitoris BA, Comper WD: The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 2007;71:504-513.
29.
Dickson LE, Wagner MC, Sandoval RM, Molitoris BA: The proximal tubule and albuminuria: really! J Am Soc Nephrol 2014;25:443-453.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.